Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Onychomycosis: early-phase trial registry
A small indexed set (12 trials) with no open enrollment listed right now.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · none currently recruiting · #1,429 of 28,707 conditions by registered trial count
Onychomycosis: 12 US clinical trials tracked, none currently recruiting.
Onychomycosis is the subject of 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Meiji Seika Pharma Co., running 2 of these trials.
Enrollment posture brief
Registry condition onychomycosis
OPEN 0 | RECR 0% | LATE 1 | EARLY 5 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of the Gastroesophageal Junction (0% recruiting · 8 trials)
Onychomycosis has no open enrollment in this registry pull (12 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Onychomycosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Onychomycosis is recruiting below its size-band peers.
0 of 12 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Onychomycosis research.
Meiji Seika Pharma Co. accounts for 2 of 12 trials (16.7%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Onychomycosis trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 12 trials that report a genuine target (sentinel values excluded). 9 of those (75%) plan for fewer than 100 participants.
-
Onychomycosis research is mostly interventional.
11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
12 total, page 1 of 1
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
Moberg Pharma AB
NCT05279846
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
Meiji Seika Pharma Co.
NCT02022215
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
Erchonia Corporation
NCT01534689
Spread of Dermatophytes Among Families
University Hospitals Cleveland Medical Center
NCT00233493
Diode Laser Treatment of Onychomycosis
ConBio, a Cynosure Company
NCT01452490
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
Roxane Laboratories
NCT00602251
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
Roxane Laboratories
NCT00602342
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
Stanford University
NCT01666002
Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis
Galderma R&D
NCT00941317
Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
Nitric BioTherapeutics
NCT01484145
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
Meiji Seika Pharma Co.
NCT01841996
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
Pfizer
NCT00679601
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Onychomycosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Onychomycosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Onychomycosis page
12 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Onychomycosis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Meiji Seika Pharma Co. sponsors the most Onychomycosis trials on record, review their full trial history before evaluating a specific study. See Meiji Seika Pharma Co.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Onychomycosis condition card totals 12 registered trials; most-linked intervention Terbinafine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.